Tissue Sealants - Medical Devices Pipeline Assessment, 2017

2017-10-01
Price :
Published : Oct-2017
No. of Pages : 173
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Tissue Sealants Overview 10
3 Products under Development 11
3.1 Tissue Sealants - Pipeline Products by Stage of Development 11
3.2 Tissue Sealants - Pipeline Products by Segment 12
3.3 Tissue Sealants - Pipeline Products by Territory 13
3.4 Tissue Sealants - Pipeline Products by Regulatory Path 14
3.5 Tissue Sealants - Pipeline Products by Estimated Approval Date 15
3.6 Tissue Sealants - Ongoing Clinical Trials 16
4 Tissue Sealants - Pipeline Products under Development by Companies 17
4.1 Tissue Sealants Companies - Pipeline Products by Stage of Development 17
4.2 Tissue Sealants - Pipeline Products by Stage of Development 19
5 Tissue Sealants Companies and Product Overview 21
5.1 Adhesys Medical GmbH Company Overview 21
5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Advanced Medical Solutions Group plc Company Overview 24
5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 24
5.3 Argon Medical Devices Inc Company Overview 26
5.3.1 Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Baxter International Inc Company Overview 27
5.4.1 Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.5 Biomedica Management Corp Company Overview 28
5.5.1 Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.6 Boston University Company Overview 29
5.6.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 29
5.7 C. R. Bard Inc Company Overview 30
5.7.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.8 Clemson University Company Overview 32
5.8.1 Clemson University Pipeline Products & Ongoing Clinical Trials Overview 32
5.9 Cohera Medical Inc Company Overview 33
5.9.1 Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.10 Covalent Medical, Inc. (Inactive) Company Overview 39
5.10.1 Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
5.11 DSM Biomedical BV Company Overview 40
5.11.1 DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 40
5.12 Emory University Company Overview 41
5.12.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 41
5.13 Ethicon Endo-Surgery Inc Company Overview 42
5.13.1 Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 42
5.14 Gamma Therapeutics Inc Company Overview 43
5.14.1 Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 43
5.15 Gecko Biomedical Company Overview 44
5.15.1 Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 44
5.16 Grifols SA Company Overview 45
5.16.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 45
5.17 Hemostasis LLC Company Overview 46
5.17.1 Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 46
5.18 HyperBranch Medical Technology Inc Company Overview 48
5.18.1 HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 48
5.19 Institute of Molecular Biology of Parana Company Overview 50
5.19.1 Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 50
5.20 InVivo Therapeutics Corp Company Overview 51
5.20.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
5.21 John Hopkins University Company Overview 52
5.21.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 52
5.22 Kollodis BioSciences Inc Company Overview 53
5.22.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
5.23 Kuros Biosciences AG Company Overview 54
5.23.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 54
5.24 LifeBond Ltd Company Overview 55
5.24.1 LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.25 Medisse BV (Inactive) Company Overview 59
5.25.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59
5.26 Pharming Group NV Company Overview 60
5.26.1 Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 60
5.27 Polyganics BV Company Overview 61
5.27.1 Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 61
5.28 Protein Polymer Technologies Inc (Inactive) Company Overview 66
5.28.1 Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66
5.29 Sea Run Holdings Inc Company Overview 67
5.29.1 Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 67
5.30 Sealantis Ltd. Company Overview 68
5.30.1 Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.31 Shanghai Haohai Biological Technology Co Ltd Company Overview 70
5.31.1 Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
5.32 Surgical Sealants, Inc. Company Overview 72
5.32.1 Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.33 Teijin Pharma Ltd Company Overview 73
5.33.1 Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
5.34 Texas A&M University Company Overview 74
5.34.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 74
5.35 The Medicines Company Company Overview 76
5.35.1 The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview 76
5.36 University of Akron Company Overview 77
5.36.1 University of Akron Pipeline Products & Ongoing Clinical Trials Overview 77
6 Tissue Sealants- Recent Developments 78
6.1 Sep 13, 2017: Advanced Medical Solutions: Interim Results for the six months ended 30 June 2017 78
6.2 Sep 05, 2017: Polyganics Extends Global Distribution Network with the Addition of Multiple US Distributors 78
6.3 Aug 30, 2017: Medline Remains Operational Through Hurricane Harvey and Current Recovery 79
6.4 Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 80
6.5 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 80
6.6 Aug 09, 2017: The Medicines Company Reports Second Quarter 2017 Business and Financial Results 83
6.7 Jul 31, 2017: Advanced Medical Solutions Group Reports H1 2016 Results 85
6.8 Jul 28, 2017: Grifols increases its revenues by 12.3% to EUR 2,192 million driven by growth of its main divisions 85
6.9 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 92
6.10 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 94
6.11 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 95
6.12 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 97
6.13 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer 97
6.14 Jun 28, 2017: Living Values, Aligning Action: Medline Amplifies Commitment to Socially Responsible Business Growth and Impact 98
6.15 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 99
6.16 May 24, 2017: Gecko Biomedical Appoints Youssef Biadillah as Chief Development Officer. Maria Pereira Transitions to Chief Innovation Officer 102
6.17 May 11, 2017: Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update 103
6.18 May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures 104
6.19 May 03, 2017: Bioscience Division sales increase 15% to drive Grifols' revenue growth by 11% to Euros 1,062 million 105
6.20 May 02, 2017: Medline Names New President of Canadian Business 110
6.21 Apr 28, 2017: Kuros Biosciences Proposes Election of Four New Board Members 110
6.22 Apr 28, 2017: Advanced Medical Solutions Group Reports 2016 Financial Results 111
6.23 Apr 26, 2017: Baxter Reports First-Quarter 2017 Results and Increases Financial Outlook for Full-Year 2017 111
6.24 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 113
6.25 Apr 26, 2017: The Medicines Company Reports First-Quarter 2017 Financial Results 114
6.26 Apr 26, 2017: Kuros Biosciences Reports Financial Results for 2016 115
6.27 Apr 23, 2017: Bard Announces First Quarter Results 116
6.28 Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 117
6.29 Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 119
6.30 Apr 13, 2017: Kuros announces CEO succession 121
6.31 Apr 03, 2017: Cesca Therapeutics Announces Senior Management Promotions 121
6.32 Mar 31, 2017: The Medicines Company Appoints Paris Panayiotopoulos to Its Board of Directors 122
6.33 Mar 14, 2017: Advanced Medical Solutions Group: Unaudited preliminary Results for the year ended 31 December 2016 122
6.34 Mar 06, 2017: Medline Announces New Chief Marketing Officer 123
6.35 Feb 28, 2017: Grifols' revenues exceed Euros 4,000 million, driven by +6.5% growth of the Bioscience Division 124
6.36 Feb 28, 2017: The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results 133
6.37 Feb 28, 2017: Cesca Therapeutics Strengthens Leadership Team and Board of Directors 135
6.38 Feb 22, 2017: LifeBond's Multi-Center International Pivotal Study of the LifeSeal Surgical Sealant for GI Resections is Enrolling Patients in the US and Europe 135
6.39 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 136
6.40 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 139
6.41 Feb 13, 2017: Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update 139
6.42 Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board 140
6.43 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 141
6.44 Feb 06, 2017: Teijin Board Elects Akihisa Nabeshima as New President of Teijin Pharma 141
6.45 Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results 141
6.46 Jan 26, 2017: Bard Announces Fourth Quarter Results 144
6.47 Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 144
6.48 Jan 17, 2017: Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors 147
6.49 Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 147
6.50 Jan 03, 2017: Breakthrough Surgical Sealant Designed to Help Reduce Anastomotic Leaks for Patients Undergoing Colorectal Surgery 148
6.51 Dec 30, 2016: Medline Makes it Easier for Patients to Receive Critical Supplies through New Patient Home Direct Deal with ViaQuest 149
6.52 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 150
6.53 Nov 17, 2016: Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update 153
6.54 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 154
6.55 Nov 08, 2016: Sales of the Bioscience Division grow by +6.5%, increasing Grifols' revenues to EUR 2,952 million 154
6.56 Nov 04, 2016: InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update 158
6.57 Nov 03, 2016: DSM Q3 2016 Results 159
6.58 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 162
6.59 Oct 26, 2016: The Medicines Company Reports Third-Quarter 2016 Financial Results 162
6.60 Oct 25, 2016: EVARREST Fibrin Sealant Patch Gains FDA Approval On Expanded Indication For General Hemostasis 164
6.61 Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016 165
6.62 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 166
6.63 Oct 25, 2016: Bard Announces Third Quarter Results 167
6.64 Oct 18, 2016: Johnson & Johnson Reports 2016 Third-Quarter Results 167
6.65 Oct 14, 2016: Medline is Expanding Manufacturing in Georgia, and Adding Jobs 169
7 Appendix 170
7.1 Methodology 170
7.2 About GlobalData 173
7.3 Contact Us 173
7.4 Disclaimer 173

1.1 List of Tables
Table 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Table 2: Tissue Sealants - Pipeline Products by Segment 12
Table 3: Tissue Sealants - Pipeline Products by Territory 13
Table 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Table 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Table 6: Tissue Sealants - Ongoing Clinical Trials 16
Table 7: Tissue Sealants Companies - Pipeline Products by Stage of Development 17
Table 8: Tissue Sealants - Pipeline Products by Stage of Development 19
Table 9: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 21
Table 10: CUTIS - Product Status 21
Table 11: CUTIS - Product Description 21
Table 12: Tissue Adhesive - Pancreatectomy - Product Status 22
Table 13: Tissue Adhesive - Pancreatectomy - Product Description 22
Table 14: VIVO - Product Status 22
Table 15: VIVO - Product Description 23
Table 16: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 24
Table 17: LiquiBand - Product Status 24
Table 18: LiquiBand - Product Description 24
Table 19: Next Generation Internal Fixation And Sealant Device - Product Status 25
Table 20: Next Generation Internal Fixation And Sealant Device - Product Description 25
Table 21: Argon Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 22: Hemaseel HMN Fibrin Sealant - Product Status 26
Table 23: Hemaseel HMN Fibrin Sealant - Product Description 26
Table 24: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 27
Table 25: Tisseel Dura - Product Status 27
Table 26: Tisseel Dura - Product Description 27
Table 27: Biomedica Management Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 28: ClotBlock - Product Status 28
Table 29: ClotBlock - Product Description 28
Table 30: Boston University Pipeline Products & Ongoing Clinical Trials Overview 29
Table 31: Hydrogel-based Aerosolized Sealant Dressing - Product Status 29
Table 32: Hydrogel-based Aerosolized Sealant Dressing - Product Description 29
Table 33: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 34: Progel Dural Sealant - Product Status 30
Table 35: Progel Dural Sealant - Product Description 30
Table 36: Progel Emerald - Product Status 31
Table 37: Progel Emerald - Product Description 31
Table 38: Tridyne Peripheral - Product Status 31
Table 39: Tridyne Peripheral - Product Description 31
Table 40: Clemson University Pipeline Products & Ongoing Clinical Trials Overview 32
Table 41: Surgical Adhesive Hydrogel - Product Status 32
Table 42: Surgical Adhesive Hydrogel - Product Description 32
Table 43: Cohera Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 44: Sylys Surgical Sealant - Product Status 33
Table 45: Sylys Surgical Sealant - Product Description 34
Table 46: Sylys Surgical Sealant - Drug Delivery - Product Status 34
Table 47: Sylys Surgical Sealant - Drug Delivery - Product Description 34
Table 48: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Status 35
Table 49: Sylys Surgical Sealant - Hernia Mesh Fixation - Product Description 35
Table 50: Sylys Surgical Sealant - Orthopedic Procedures - Product Status 35
Table 51: Sylys Surgical Sealant - Orthopedic Procedures - Product Description 36
Table 52: Cohera Medical Inc - Ongoing Clinical Trials Overview 37
Table 53: Sylys Surgical Sealant - A Pilot, Prospective, Randomized, Controlled, Multicenter Technical Feasibility Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Techniques Plus Sylys Surgical Sealant 38
Table 54: Sylys Surgical Sealant - A Pivotal, Prospective, Randomized, Controlled, Multi-center Superiority Clinical Study Comparing Standard Anastomosis Closure Technique to Standard Closure Technique Plus Sylys Surgical Sealant 38
Table 55: Covalent Medical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 39
Table 56: Covabond - Product Status 39
Table 57: Covabond - Product Description 39
Table 58: DSM Biomedical BV Pipeline Products & Ongoing Clinical Trials Overview 40
Table 59: Dural Membrane Sealant - Product Status 40
Table 60: Dural Membrane Sealant - Product Description 40
Table 61: Emory University Pipeline Products & Ongoing Clinical Trials Overview 41
Table 62: Steroidal Hemostatic Surgical Adhesive - Product Status 41
Table 63: Steroidal Hemostatic Surgical Adhesive - Product Description 41
Table 64: Ethicon Endo-Surgery Inc Pipeline Products & Ongoing Clinical Trials Overview 42
Table 65: Bioseal Next Gen Device - Product Status 42
Table 66: Bioseal Next Gen Device - Product Description 42
Table 67: Gamma Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 68: GammaSeal - Product Status 43
Table 69: GammaSeal - Product Description 43
Table 70: Gecko Biomedical Pipeline Products & Ongoing Clinical Trials Overview 44
Table 71: Bio-Inspired Surgical Liquid Film - Product Status 44
Table 72: Bio-Inspired Surgical Liquid Film - Product Description 44
Table 73: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview 45
Table 74: Fibrin Biological Glue - Product Status 45
Table 75: Fibrin Biological Glue - Product Description 45
Table 76: Hemostasis LLC Pipeline Products & Ongoing Clinical Trials Overview 46
Table 77: Advanced Tissue Sealant - Product Status 46
Table 78: Advanced Tissue Sealant - Product Description 46
Table 79: Bioabsorbable Bone Sealant - Product Status 47
Table 80: Bioabsorbable Bone Sealant - Product Description 47
Table 81: HyperBranch Medical Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 48
Table 82: Adherus Vascular Sealant - Product Status 48
Table 83: Adherus Vascular Sealant - Product Description 48
Table 84: Tissue Plane Sealant - Product Status 49
Table 85: Tissue Plane Sealant - Product Description 49
Table 86: Institute of Molecular Biology of Parana Pipeline Products & Ongoing Clinical Trials Overview 50
Table 87: Recombinant Fibrin Glue - Product Status 50
Table 88: Recombinant Fibrin Glue - Product Description 50
Table 89: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
Table 90: InVivoSeal - Product Status 51
Table 91: InVivoSeal - Product Description 51
Table 92: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 52
Table 93: Chondroitin Sulfate-based Adhesive - Product Status 52
Table 94: Chondroitin Sulfate-based Adhesive - Product Description 52
Table 95: Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview 53
Table 96: Hemostat Sealant - Product Status 53
Table 97: Hemostat Sealant - Product Description 53
Table 98: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 54
Table 99: KUR - 212 - Product Status 54
Table 100: KUR - 212 - Product Description 54
Table 101: LifeBond Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
Table 102: LifeSeal Surgical Sealant - Product Status 55
Table 103: LifeSeal Surgical Sealant - Product Description 55
Table 104: Tissue Adhesive - Product Status 56
Table 105: Tissue Adhesive - Product Description 56
Table 106: LifeBond Ltd - Ongoing Clinical Trials Overview 57
Table 107: LifeSeal Surgical Sealant - Efficacy and Safety of LifeSeal Kit for Staple Line Sealing in Colorectal and Coloanal Anastomoses: A Prospective Randomized Study 58
Table 108: LifeSeal Surgical Sealant - Observational, Retrospective and Prospective, One Arm, Registry Study for the Effectiveness of LifeSeal Kit on Anastomotic Leaks in Patients Undergoing Low and Ultralow Anterior Resection: SEAL Registry 58
Table 109: Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 59
Table 110: PTMC Sealant - Product Status 59
Table 111: PTMC Sealant - Product Description 59
Table 112: Pharming Group NV Pipeline Products & Ongoing Clinical Trials Overview 60
Table 113: Recombinant Fibrin Tissue Sealant - Product Status 60
Table 114: Recombinant Fibrin Tissue Sealant - Product Description 60
Table 115: Polyganics BV Pipeline Products & Ongoing Clinical Trials Overview 61
Table 116: Dura Sealant Patch - Product Status 61
Table 117: Dura Sealant Patch - Product Description 61
Table 118: Liver Sealant Patch - Product Status 62
Table 119: Liver Sealant Patch - Product Description 62
Table 120: Pancreas Sealant Patch - Product Status 62
Table 121: Pancreas Sealant Patch - Product Description 63
Table 122: Spine Sealant Patch - Product Status 63
Table 123: Spine Sealant Patch - Product Description 63
Table 124: Polyganics BV - Ongoing Clinical Trials Overview 64
Table 125: Dura Sealant Patch - A Randomized Controlled Study to Evaluate the Efficacy and Safety of Fibrin Sealant, Vapour Heated, Solvent/Detergent Treated (FS VH S/D 500 S-apr) Compared to DuraSeal Dural Sealant as an Adjunct to Sutured Dural Repair in Cranial Surgery 65
Table 126: Protein Polymer Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66
Table 127: Surgical Tissue Sealant - Product Status 66
Table 128: Surgical Tissue Sealant - Product Description 66
Table 129: Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 67
Table 130: SEA-STAT CNS - Product Status 67
Table 131: SEA-STAT CNS - Product Description 67
Table 132: Sealantis Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
Table 133: Seal-G - Product Status 68
Table 134: Seal-G - Product Description 68
Table 135: Sealantis Tissue Adhesive - Product Status 69
Table 136: Sealantis Tissue Adhesive - Product Description 69
Table 137: Shanghai Haohai Biological Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
Table 138: Fibrinsealant - Product Status 70
Table 139: Fibrinsealant - Product Description 70
Table 140: Fibrinsealant Powder - Product Status 71
Table 141: Fibrinsealant Powder - Product Description 71
Table 142: Surgical Sealants, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 143: Thorex - Product Status 72
Table 144: Thorex - Product Description 72
Table 145: Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 73
Table 146: KTF-374 Fibrin Sealant - Product Status 73
Table 147: KTF-374 Fibrin Sealant - Product Description 73
Table 148: Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 74
Table 149: Tissue Welding Device - Product Status 74
Table 150: Tissue Welding Device - Product Description 74
Table 151: Wound Healing and Tissue Repair Bandage - Product Status 75
Table 152: Wound Healing and Tissue Repair Bandage - Product Description 75
Table 153: The Medicines Company Pipeline Products & Ongoing Clinical Trials Overview 76
Table 154: Prevent GI Sealant - Product Status 76
Table 155: Prevent GI Sealant - Product Description 76
Table 156: University of Akron Pipeline Products & Ongoing Clinical Trials Overview 77
Table 157: Wound Closure Glue - Product Status 77
Table 158: Wound Closure Glue - Product Description 77
Table 159: Glossary 172

1.2 List of Figures
Figure 1: Tissue Sealants - Pipeline Products by Stage of Development 11
Figure 2: Tissue Sealants - Pipeline Products by Segment 12
Figure 3: Tissue Sealants - Pipeline Products by Territory 13
Figure 4: Tissue Sealants - Pipeline Products by Regulatory Path 14
Figure 5: Tissue Sealants - Pipeline Products by Estimated Approval Date 15
Figure 6: Tissue Sealants - Ongoing Clinical Trials 16
Filed in: Medical Device
Publisher : GlobalData